The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
The FDA is beginning rulemaking to close the “adequate provision” loophole
Subscribe To Our Newsletter & Stay Updated
